secwatch.observer — SEC 8-K summary
======================================

Issuer:     InspireMD, Inc. (NSPR)
CIK:        0001433607
Form:       8-K
Filed at:   2025-06-13T23:59:59+00:00
Accession:  0001641172-25-014986
Event type: regulatory
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InspireMD receives CE Mark approval for CGuard Prime EPS under EU MDR
---------------------------------------------------------------------

- CE Mark approval under European Medical Device Regulation (MDR) for CGuard Prime Embolic Prevention System.
- Product designed with MicroNet mesh to reduce embolic events and prevent stroke.
- Approval clears path for commercial launch in current CE-marked served markets.
- Same platform intended for US launch later in 2025, subject to FDA approval.
- CEO Marvin Slosman highlights regulatory milestone and next-generation platform advancement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1433607/000164117225014986/0001641172-25-014986-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1433607/000164117225014986/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-014986

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer